Search for: "Lewis v. Moore" Results 101 - 120 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Apr 2021, 12:23 pm by Adam Faderewski
• Jacqueline Moore Gifford, 81, of Houston, died January 15, 2021. [read post]
29 Dec 2017, 7:34 am by Ben
In the UK in FAPL v BT [2017] Mr Justice Arnold concluded that the High Court has the jurisdiction to make an order against an access provider that would require the ISP to block access not to a website but rather streaming servers giving unauthorised access to copyright content - 'live' blocking. [read post]
14 Mar 2012, 7:57 am by Rob Robinson
High Court to Weigh Warrantless Use of GPS in Non-Criminal Cases - bit.ly/wZTp7P (Theresa Marangas, Benjamin Neidl) Open Records and FOIA – Pushing Government Technology into the 21st Century - bit.ly/xv2Ulg (Heidi Maher) Patel v Unite – Order For Investigation of Deleted Internet Forum - bit.ly/xsuqj7 (Chris Dale) Perspective on Legal Search and Document Review – bit.ly/wfbqR0 (Ralph Losey) Policy vs. [read post]
25 Jun 2012, 8:29 am by familoo
Yours faithfully Solicitors David Jockelson Miles and Partners Kate Hammond Miles and partners Sarah Cove Miles and Partners Amanda Dench Miles and Partners Pauline Lloyd Ewings & Co Peggy Ray Goodman Ray Gwen Williams Goodman Ray Hilka Hollmann Goodman Ray Joanna Bosanquet  Goodman Ray Michael Bourdages Goodman Ray Christina Blacklaws  TV Edwards David Emmerson T V Edwards Lorraine Green TV Edwards Susan Fitzgerald TV Edwards Valerie Greenfield  Fisher Meredith LLP… [read post]
12 Mar 2012, 8:13 am by Ronald Collins
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
11 Feb 2011, 7:51 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Oct 2010, 8:43 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]